Story perspectives

Oura Postpones Nasdaq IPO, Citing Uncertain Market

By Drooid · Sep 29, 2026, 2:04 PM UTC · How we work

Summary

Story summary

Oura Health postponed its Nasdaq IPO, citing uncertainty in the IPO market.
CEO Tom Hale said the company faces strong demand but can choose its timing.
The offering would have sold 50 million shares at $40-$44 each, targeting up to $2.2 billion.
Oura reported 5.7 million paid members.
Oura is profitable and expects fiscal-2026 revenue to grow 90 percent year-over-year.

History

Historical Context

In March 2000 the Nasdaq Composite peaked at 5,048.62 before falling 78% by October 2002, wiping out billions in tech valuations. Companies such as Cisco and Amazon saw stock values plunge 80% and over 90% respectively, prompting many to delay IPOs. Oura Health’s 2024 decision to postpone its $2.2 billion Nasdaq offering echoes those same market-timing concerns.

1 of 2

Story summary

Oura Health postponed its Nasdaq IPO, citing uncertainty in the IPO market.
CEO Tom Hale said the company faces strong demand but can choose its timing.
The offering would have sold 50 million shares at $40-$44 each, targeting up to $2.2 billion.
Oura reported 5.7 million paid members.
Oura is profitable and expects fiscal-2026 revenue to grow 90 percent year-over-year.

1 / 2